Drop-Ship Kits Today – Our Current GI-MAP Turnaround Time: 7–10 Business Days

qPCR Testing for GI Pathogens

Wednesday, January 13, 2021

Methodology Matters in Diagnostic Stool Testing

By David M. Brady, ND, DC, CCN, DACBN, IFMCP, FACN and Cass Nelson-Dooley, MS

Our Chief Medical Officer, Dr. David Brady, is featured on the cover of the January 2021 issue of the Townsend Letter. Read the article, "Methodology Matters in Diagnostic Stool Testing."

Dr. Brady describes the different methodologies used to evaluate gut health and why qPCR offers the most sensitive, specific, reliable results when addressing acute and chronic gastrointestinal illness in a clinical setting.

Article highlights:

  • Molecular Methods Revolutionize Diagnostic Testing
  • Methods of Stool Testing Defined
  • Culture and Microscopic Methodologies
  • Advantages of Quantitative Molecular (qPCR) Technology in Clinical Settings
  • Discussion – The Molecular Revolution
  • References

Please Note: This button opens the article in a new window on the Townsend Letter site.

Read the Article


@dxsolutionslab we love the #gimap ... It teaches us so much about our patient's health ... Beta-glucuronidase can be tested with the GI-MAP test.
- Healthcare Professional - Why Test Beta-Glucuronidase
Methodology Matters - Dr. David Brady


Results You Can Rely On

Research indicates that gut health impacts every area of human health.

GI-MAP - DNA Stool Analysis by Quantitative PCR

Optimal health – it all starts with the GI-MAPComprehensive DNA Stool Analysis via qPCR.

Learn More